Â
WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S AND PARKINSON’S DISEASE, INCLUDING THE ORPHAN INDICATION DEMENTIA AND ALZHEIMER’S IN DOWN SYNDROME
​
Our novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population
ALZHEIMER'S DISEASE DRUG FAILURE
Amyloid Plaque and Aβ is NOT The Only Answer
After amyloid failures, it’s time to take a new tack for treating Alzheimer’s
Raymond J. Tesi STAT News April 30, 2019
